Almirall, S.A. (ALM.MC)
EUR 9.94
(1.95%)
EUR 9.94
(1.95%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 122.51 Million EUR | -10.2% |
| 2022 | 165.06 Million EUR | -17.39% |
| 2021 | 132.33 Million EUR | -0.34% |
| 2020 | 220.87 Million EUR | -19.95% |
| 2019 | 273.05 Million EUR | 25.57% |
| 2018 | 173.09 Million EUR | 99.23% |
| 2017 | -212.18 Million EUR | -37.06% |
| 2016 | 213.07 Million EUR | -2.19% |
| 2015 | 247.3 Million EUR | -71.88% |
| 2014 | 570.81 Million EUR | 823.61% |
| 2013 | -16.47 Million EUR | -40.35% |
| 2012 | 124.78 Million EUR | -29.73% |
| 2011 | 149.9 Million EUR | -11.66% |
| 2010 | 198 Million EUR | -15.58% |
| 2009 | 253.4 Million EUR | -76.62% |
| 2008 | 228.4 Million EUR | 408.51% |
| 2007 | 179.63 Million EUR | 15.19% |
| 2006 | 182.68 Million EUR | 0.25% |
| 2005 | 175.37 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 103.27 Million EUR | 357.78% |
| 2024 Q1 | 18.5 Million EUR | -22.47% |
| 2023 Q1 | 47.9 Million EUR | -38.12% |
| 2023 Q3 | 51.19 Million EUR | -34.4% |
| 2023 FY | - EUR | -10.2% |
| 2023 Q4 | 65.64 Million EUR | 28.21% |
| 2023 Q2 | 78.04 Million EUR | 62.92% |
| 2022 Q2 | 76.95 Million EUR | 37.66% |
| 2022 Q1 | 55.9 Million EUR | 208.99% |
| 2022 FY | - EUR | -17.39% |
| 2022 Q4 | 77.4 Million EUR | 0.0% |
| 2021 Q1 | 67.4 Million EUR | 113.36% |
| 2021 Q3 | 151.12 Million EUR | 106.23% |
| 2021 Q2 | 73.27 Million EUR | 8.72% |
| 2021 FY | - EUR | -0.34% |
| 2021 Q4 | -51.28 Million EUR | -133.94% |
| 2020 Q2 | 50.76 Million EUR | -43.91% |
| 2020 Q3 | 68.73 Million EUR | 35.4% |
| 2020 FY | - EUR | -19.95% |
| 2020 Q4 | 31.59 Million EUR | -54.04% |
| 2020 Q1 | 90.5 Million EUR | 59.83% |
| 2019 FY | - EUR | 25.57% |
| 2019 Q4 | 56.62 Million EUR | -35.1% |
| 2019 Q2 | 77.05 Million EUR | -3.08% |
| 2019 Q3 | 87.24 Million EUR | 13.23% |
| 2019 Q1 | 79.5 Million EUR | -27.54% |
| 2018 Q1 | 58.1 Million EUR | 147.58% |
| 2018 FY | - EUR | 99.23% |
| 2018 Q2 | 45.3 Million EUR | -22.02% |
| 2018 Q4 | 109.71 Million EUR | 274.49% |
| 2018 Q3 | 29.29 Million EUR | -35.33% |
| 2017 Q4 | -122.1 Million EUR | -226.19% |
| 2017 FY | - EUR | -37.06% |
| 2017 Q2 | -70.4 Million EUR | -228.24% |
| 2017 Q3 | 96.76 Million EUR | 237.44% |
| 2017 Q1 | 54.9 Million EUR | 108.29% |
| 2016 Q4 | 26.35 Million EUR | -56.59% |
| 2016 FY | - EUR | -2.19% |
| 2016 Q1 | 54.8 Million EUR | 11245.76% |
| 2016 Q3 | 60.72 Million EUR | -32.93% |
| 2016 Q2 | 90.53 Million EUR | 65.2% |
| 2015 Q4 | 483 Thousand EUR | -99.35% |
| 2015 Q3 | 74.01 Million EUR | 107.7% |
| 2015 Q2 | 35.63 Million EUR | -51.25% |
| 2015 FY | - EUR | -71.88% |
| 2015 Q1 | 73.1 Million EUR | -86.55% |
| 2014 Q1 | 31.6 Million EUR | 556.42% |
| 2014 FY | - EUR | 823.61% |
| 2014 Q4 | 543.49 Million EUR | 1052.53% |
| 2014 Q3 | 47.15 Million EUR | 57.94% |
| 2014 Q2 | 29.85 Million EUR | -5.52% |
| 2013 Q3 | 22.55 Million EUR | 3.89% |
| 2013 FY | - EUR | -40.35% |
| 2013 Q1 | 20.1 Million EUR | -8.58% |
| 2013 Q4 | 4.81 Million EUR | -78.66% |
| 2013 Q2 | 21.71 Million EUR | 8.03% |
| 2012 Q3 | 98.34 Million EUR | 361.62% |
| 2012 Q1 | 31.3 Million EUR | 114.29% |
| 2012 FY | - EUR | -29.73% |
| 2012 Q2 | 21.3 Million EUR | -31.94% |
| 2012 Q4 | 21.98 Million EUR | -77.64% |
| 2011 Q2 | 56.7 Million EUR | 6.38% |
| 2011 Q1 | 53.3 Million EUR | 120.34% |
| 2011 Q3 | 258.1 Million EUR | 355.2% |
| 2011 Q4 | -218.99 Million EUR | -184.85% |
| 2011 FY | - EUR | -11.66% |
| 2010 Q4 | -262.1 Million EUR | -182.68% |
| 2010 FY | - EUR | -15.58% |
| 2010 Q1 | 78.2 Million EUR | 134.85% |
| 2010 Q2 | 56.1 Million EUR | -28.26% |
| 2010 Q3 | 317 Million EUR | 465.06% |
| 2009 Q4 | -224.4 Million EUR | -169.11% |
| 2009 Q1 | 79.2 Million EUR | 0.0% |
| 2009 FY | - EUR | -76.62% |
| 2009 Q3 | 324.7 Million EUR | 404.19% |
| 2009 Q2 | 64.4 Million EUR | -18.69% |
| 2008 FY | - EUR | 408.51% |
| 2007 FY | - EUR | 15.19% |
| 2006 FY | - EUR | 0.25% |
| 2005 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Faes Farma, S.A. | 122.93 Million EUR | 0.342% |
| Laboratorio Reig Jofre, S.A. | 35.13 Million EUR | -248.682% |